This is supported by our finding that MEK1/2 inhibition, but not EGFR inhibition, prevented HGF‐induced PD‐L1 expression and by earlier findings in renal cell carcinoma 46. This evidence concerns the gene MAP2K1 and hereditary clear cell renal cell carcinoma.